Schott Pharma AG & CO KGaA annual operating income
2020
2021
2022
2023
2024
2025
Schott Pharma AG & CO KGaA Operating Income Growth & History (1SXP)
Schott Pharma AG & CO KGaA's operating income was €200.8M for fiscal 2025.
View full Schott Pharma AG & CO KGaA company overviewSchott Pharma AG & CO KGaA annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | €200.8M | €8.2M | +4.28% |
| 2024 | 2024-09-30 | €192.6M | €193,000 | +0.10% |
| 2023 | 2023-09-30 | €192.4M | €28.0M | +17.04% |
| 2022 | 2022-09-30 | €164.4M | €50.4M | +44.25% |
| 2021 | 2021-09-30 | €114.0M | €21.3M | +22.98% |
| 2020 | 2020-09-30 | €92.7M | — | — |
Schott Pharma AG & CO KGaA quarterly operating income
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | €48.9M | −€11.1M | −18.46% |
| Q2 2026 | 2026-03-31 | €39.5M | −€9.8M | −19.84% |
| Q1 2026 | 2025-12-31 | €39.0M | — | — |
| Q4 2025 | 2025-09-30 | €41.4M | — | — |
| Q3 2025 | 2025-06-30 | €60.0M | — | — |
| Q2 2025 | 2025-03-31 | €49.3M | — | — |
Schott Pharma AG & CO KGaA operating income trends
Over the last five fiscal years, Schott Pharma AG & CO KGaA's operating income increased from €92.7M to €200.8M, a change of €108.2M. The latest reported quarter, Q3 2026, shows €48.9M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
reported operating income
TickerStat standardizes operating income reported in company official filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Schott Pharma AG & CO KGaA source filings ↗